The dosage table
It states plainly that a 15.47 mg blend is small next to the doses used in published research. It is the first thing a careful buyer reads and the most likely single reason someone does not buy.
A stocking partner that earns when you buy, publishing the unflattering facts anyway, with a method you can check line by line.
This site is published by Cognizil Daily, the U.S. stocking partner for Cognizil, from 10 East 40th Street, Floor 17, New York, NY 10016. Pages are written by the Cognizil Daily Editorial Desk and medically reviewed by Dr. Mary Cunningham, a neuropsychologist. The site earns a commission on orders placed through it, which is disclosed on every page.
Dr. Mary Cunningham is a neuropsychologist and the medical reviewer for cognizildaily.com. Dr. Mary Cunningham reads the product copy, the label transcription, the ingredient and safety pages and every journal post, and flags anything inaccurate, unsafe or stronger than the label allows.
The Cognizil Daily Editorial Desk writes the pages and remains their author. The review is a check on them, not an endorsement of Cognizil and not medical advice for any one reader. The current review covers the September 2026 edition of the site, and the editorial standards explain how a changed page goes back for review.
Five rules. They are checkable, which is the only kind of promise worth making.
Every ingredient, amount, claim and caution on this site is read off the printed panel of the bottle. Where the label and a marketing page disagree, the label wins and we say that it did.
If we were not given a figure, the page says not published. It does not say roughly, or typically, or industry standard. The list of everything we are missing is on this page.
Every study cited on this site is one we opened and read. No PubMed identifier appears here that we did not check. Where a study found nothing, we print that it found nothing.
The desk that writes is named as the author, and the medical reviewer is named with a real credential. There is no stock-photo reviewer and no made-up credential anywhere on this site.
When we fix something, the last-updated date on that page moves forward. If a page has an old date, nothing on it has changed since then.
Cognizil Daily is the U.S. stocking partner for Cognizil and earns on orders placed through this site. If you buy after reading these pages, we are paid. That is the whole arrangement and there is nothing else behind it.
Disclosing that is easy. Behaving as though it were not true is the harder part, and it is the reason the home page carries a dosage table showing the blend is small against research doses, a complaints section, and an editorial score of 3.3 out of 5.
We would rather sell fewer bottles to people the product actually suits than more bottles to people who will ask for a refund in six weeks. A 180-day guarantee makes that more than a sentiment: an unhappy buyer costs us the sale and the handling.
Nothing on this site is paid placement. No competitor has paid to be described a particular way, and no competitor is named in a ranking anywhere on this site.
Every one of these could have been left out. None of them is here by accident.
It states plainly that a 15.47 mg blend is small next to the doses used in published research. It is the first thing a careful buyer reads and the most likely single reason someone does not buy.
A controlled study found no benefit for concentration. It is named on the home page and the how-it-works page, because a citation list that only holds positive results is not a citation list.
We tell buyers to skip the middle pack. That steers people from a $207 order to a $158 one.
Every criticism in the supplied reviews is printed at the same size as the praise, including that nobody felt anything in week one.
This list is published rather than hidden, and it is the honest limit of what this site can tell you.
Three conflicts came up while building this site. Each was resolved by the priority order above, and each resolution is printed here.
| Conflict | What we did |
|---|---|
| Phone number | The seller's brief listed no public phone. The label prints one for the distributor. The label wins, so the number appears in the site footer as the distributor's line. |
| Guarantee length | Competitor pages show a 60-day guarantee. The brief for this product says 180 days on the packs sold here. The brief wins over a competitor, so 180 days is printed. |
| Product form | The brief did not name the form. The label shows 1 oz / 30 ml and “take 1 dropperful daily”, so this is a liquid, not a capsule. |
September 30, 2026. Dr. Mary Cunningham named as medical reviewer on every page, and the sentences on this page and the disclaimer that said no reviewer was named were rewritten. Shipping charges added from the official sales page. “Alcohol-free” removed from the home headline, because the label does not print it. Three home-page headings retitled in plainer language.
Earlier changes: none since the site was published on September 22, 2026. Each future correction will be listed here with its date and what changed.
A corrections log that stays empty forever is a sign that nobody is checking, so if you find something wrong, tell us through the contact page. The page address and a sentence about what is wrong is enough.
Corrections we would act on immediately: a figure that does not match the printed panel, a study we have described inaccurately, a price that does not match the order page, or a sentence that reads as a disease claim.
Two bottles covers the four to eight week window buyers describe. Six bottles is $1.63 a day and the 180-day guarantee covers the whole supply.
Add To CartSee pricingPrices shown are what you pay · Free U.S. shipping on three or six bottles · No subscriptionCognizil Daily, the U.S. stocking partner for Cognizil. The office is at 10 East 40th Street, Floor 17, New York, NY 10016, and returns go to 880 Third Avenue, Floor 13, New York, NY 10022.
The label prints: distributed by Cognizil, PO Box 12730, Ogden, UT 84404, with a phone number and an email address, both repeated in the site footer.
Yes. Cognizil Daily is a stocking partner and earns on orders placed through this site. That is exactly why the dose gap and the critical reviews are printed here at full size.
No supplement is. The FDA states it does not have the authority to approve dietary supplements before they are marketed. The label says the product is manufactured in an FDA-registered facility, which describes the factory, not the product.
This stock is lot COG-26/CO-1168 with certificate reference COG-1168-26-CO. The lot and the best-before print on the base of the bottle.
Two bottles covers the four to eight week window buyers describe. Six bottles is $1.63 a day and the 180-day guarantee covers the whole supply.
Add To CartSee pricingPrices shown are what you pay · Free U.S. shipping on three or six bottles · No subscription